Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii
- 278 Downloads
We evaluated osteoporosis treatment and DEXA utilization rates of patients who were admitted for hip fracture in a single healthcare system in Hawaii from 2015 to 2016. We found that osteoporosis treatment and DEXA utilization rates were low, highlighting a critical gap in osteoporosis care after admission for hip fracture.
The objective of this study was to evaluate osteoporosis care after an admission for hip fracture at three community hospitals within a single healthcare system in Hawaii.
A retrospective chart review was conducted (n = 428) of patients ≥ 50 years and hospitalized for hip fractures between January 1, 2015, and May 31, 2016, at three major hospitals within Hawaii Pacific Health, a large healthcare system in Hawaii. Basic demographics were collected, and medications prescribed were quantified and described within 1 year of hip fracture. Logistic regression was used to evaluate the association between collected variables and the odds of osteoporosis treatment.
Only 115 (26.9%) patients were prescribed a medication for osteoporosis as a secondary prevention within a year of hospitalization for hip fracture. DEXA scans were performed in 137 (32.0%) patients. Most of the treated patients were prescribed oral bisphosphonates. Treatment facility, female gender, and higher BMI were found to be predictive factors for osteoporosis treatment.
The use of osteoporosis medication for secondary prevention after admission for hip fracture in Hawaii is low. Efforts need to be made to improve treatment rates, especially among males.
KeywordsHip fracture Hospitalization Osteoporosis Secondary prevention
The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
The biostatisticians are partially supported by the National Institute on Minority Health and Health Disparities (U54MD00760131).
Compliance with ethical standards
Conflicts of interest
- 3.Foster K (2017) Hip fractures in adults. UpToDate, WalthamGoogle Scholar
- 8.MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, Mojica W, Timmer M, Alexander A, McNamara M (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis preventing fractures in people with low bone density or osteoporosis. Ann Intern Med 148:197–213CrossRefPubMedGoogle Scholar
- 15.Hawaii Pacific Health (2017) Hawaii Pacific Health—about us. https://www.hawaiipacifichealth.org/about-us/overview/ Accessed 20 Nov 2017
- 23.Beaton D, Dyer S, Jiang D, Sujic R, Slater M, Sale J, Bogoch E, Team OFCSPE (2014) Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario osteoporosis strategy’s fracture clinic screening program. Osteoporos Int 25:289–296CrossRefPubMedGoogle Scholar
- 30.Counterweight Project Te (2005) The impact of obesity on drug prescribing in primary care. Br J Gen Pract 55:743–749Google Scholar
- 31.Cowie MR, Blomster JI, Curtis LH, Duclaux S, Ford I, Fritz F, Goldman S, Janmohamed S, Kreuzer J, Leenay M, Michel A, Ong S, Pell JP, Southworth MR, Stough WG, Thoenes M, Zannad F, Zalewski A (2017) Electronic health records to facilitate clinical research. Clin Res Cardiol 106:1–9CrossRefPubMedGoogle Scholar